- Home
- ERO vs NVCR Comparison
ERO vs NVCR Comparison
Compare ERO & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERO
- NVCR
- Stock Information
- Founded
- ERO 2016
- NVCR 2000
- Country
- ERO Canada
- NVCR Switzerland
- Employees
- ERO N/A
- NVCR N/A
- Industry
- ERO
- NVCR Medical/Dental Instruments
- Sector
- ERO
- NVCR Health Care
- Exchange
- ERO Nasdaq
- NVCR Nasdaq
- Market Cap
- ERO 1.5B
- NVCR 1.4B
- IPO Year
- ERO N/A
- NVCR 2015
- Fundamental
- Price
- ERO $14.03
- NVCR $11.64
- Analyst Decision
- ERO Strong Buy
- NVCR Buy
- Analyst Count
- ERO 1
- NVCR 7
- Target Price
- ERO $19.00
- NVCR $28.79
- AVG Volume (30 Days)
- ERO 878.6K
- NVCR 1.4M
- Earning Date
- ERO 07-31-2025
- NVCR 07-24-2025
- Dividend Yield
- ERO N/A
- NVCR N/A
- EPS Growth
- ERO N/A
- NVCR N/A
- EPS
- ERO 0.18
- NVCR N/A
- Revenue
- ERO $489,554,000.00
- NVCR $630,160,000.00
- Revenue This Year
- ERO $73.94
- NVCR $5.44
- Revenue Next Year
- ERO $20.16
- NVCR $9.05
- P/E Ratio
- ERO $76.06
- NVCR N/A
- Revenue Growth
- ERO 13.24
- NVCR 14.58
- 52 Week Low
- ERO $9.30
- NVCR $11.57
- 52 Week High
- ERO $23.40
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- ERO 40.16
- NVCR 21.64
- Support Level
- ERO $14.21
- NVCR $11.57
- Resistance Level
- ERO $15.03
- NVCR $16.70
- Average True Range (ATR)
- ERO 0.58
- NVCR 0.89
- MACD
- ERO -0.13
- NVCR -0.59
- Stochastic Oscillator
- ERO 17.14
- NVCR 1.00
About ERO Ero Copper Corp.
Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.